ROETTO, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 4.595
EU - Europa 2.741
AS - Asia 1.431
OC - Oceania 24
AF - Africa 16
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.821
Nazione #
US - Stati Uniti d'America 4.548
CN - Cina 883
IE - Irlanda 435
IT - Italia 417
SE - Svezia 333
FR - Francia 277
FI - Finlandia 259
DK - Danimarca 240
UA - Ucraina 218
KR - Corea 190
DE - Germania 160
BE - Belgio 99
VN - Vietnam 95
IN - India 84
JP - Giappone 74
PL - Polonia 74
GB - Regno Unito 59
AT - Austria 46
CA - Canada 40
NL - Olanda 40
AU - Australia 22
TW - Taiwan 21
HK - Hong Kong 19
PT - Portogallo 17
SG - Singapore 16
TR - Turchia 15
ES - Italia 11
RO - Romania 10
CH - Svizzera 9
RU - Federazione Russa 9
CZ - Repubblica Ceca 7
ET - Etiopia 7
BR - Brasile 6
GR - Grecia 6
ID - Indonesia 5
IL - Israele 5
MX - Messico 5
MY - Malesia 5
EU - Europa 4
IR - Iran 4
HR - Croazia 3
LB - Libano 3
LK - Sri Lanka 3
NG - Nigeria 3
NO - Norvegia 3
SN - Senegal 3
AL - Albania 2
AR - Argentina 2
BG - Bulgaria 2
EG - Egitto 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
BZ - Belize 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.821
Città #
Chandler 727
Beijing 500
Ann Arbor 445
Dublin 434
Fairfield 252
Houston 241
Ashburn 228
Villeurbanne 215
Wilmington 166
Princeton 129
Seattle 128
Medford 127
Jacksonville 123
Woodbridge 120
Dearborn 116
Torino 102
Cambridge 100
Nyköping 92
Brussels 83
Pisa 82
Warsaw 73
Redwood City 63
Boardman 59
Boston 56
Dong Ket 56
Shanghai 45
Turin 43
Vienna 43
Pune 39
Fremont 37
Nanjing 33
Düsseldorf 25
San Diego 23
Wuhan 23
San Mateo 19
Hangzhou 18
Shenyang 17
New York 16
Washington 16
Chengdu 15
Norwalk 15
Toronto 15
Changsha 14
Dresden 14
Guangzhou 14
Milan 14
Taipei 14
Phoenix 13
Waanrode 13
Nanchang 12
Hefei 11
Jinan 11
Des Moines 10
Nijmegen 10
Padova 10
Silver Spring 10
Zhengzhou 10
Falls Church 9
Hanover 9
Hebei 9
Paris 9
Tokyo 9
Chennai 8
Munich 8
Rome 8
Tianjin 8
Asciano 7
Buffalo 7
Detroit 6
Heidelberg 6
Helsinki 6
Kunming 6
Montreal 6
Xian 6
Amsterdam 5
Brisbane 5
Brno 5
Central 5
Chicago 5
Chongqing 5
Gloucester 5
London 5
Lucknow 5
Montréal 5
Napoli 5
Seoul 5
Atlanta 4
Berlin 4
Eschweiler 4
Harbin 4
Hyderabad 4
Los Angeles 4
Manitowoc 4
Modena 4
Ottawa 4
South Dennis 4
Asti 3
Baotou 3
Bethesda 3
Bloomfield 3
Totale 5.578
Nome #
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 601
Comparison of 3 Tfr2-deficient murine models suggestsdistinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues 362
A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion 291
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 236
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form 230
Hemochromatosis due to mutations in transferrin receptor 2. 207
Analysis of microsatellite instability in chronic lymphoproliferative disorders 187
A child with hyperferritinemia: case report 181
Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis 173
Development of cellular and humoral response against WT1 protein vaccination in mice 172
Rare Genetic Anemias Due to Defective Iron Recycling: Aceruloplasminemia and Type 4 Hemochromatosis 168
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). 167
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse 158
Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. 152
The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients 150
Allelic association of microsatellites of 6p in Italian hemochromatosis patients 142
The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice 133
Characterization of human mitochondrial ferritin promoter: Identification of transcription factors and evidences of epigenetic control 126
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors 125
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN 107
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 102
Construction of a YAC contig covering human chromosome 6p22 101
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling 98
Altered erythropoiesis in mouse models of type 3 Hemochromatosis (Hh3) 90
THE PHENOTYPE OF TFR2-TMPRSS6 DOUBLE KNOCK OUT MICE ONLY PARTIALLY OVERLAPS THAT OF TMPRSS6 NULL MICE 86
COMPORTAMENTO ANSIOSO NEI TOPI TFR2 KO: NUOVO COLLEGAMENTO TRA SOVRACCARICO CEREBRALE DI FERRO E ANSIA NELLE MALATTIE NEURODEGENERATIVE? 85
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA 83
Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained Iron-Overload 83
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4 82
A recombination event close to HFE gene in hereditary hemochromatosis 82
A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. 81
Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis 77
Anemia and iron overload due to genetic defects of iron recycling, aceruloplasminemia and hemochromatosis type 4 74
Patologie da sovraccarico di ferro 74
Identification of a Novel Mutation in the L Ferritin Iron-Responsive Element Causing Hereditary Hyperferritinemia-Cataract Syndrome 73
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value 72
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing 70
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia - response to Jasperset al 70
Construction of a genetic map telomeric to HAL-A by microsatellite analysis 69
Detection of humoral immune responses against WT1 antigenin patients affected by different hematological malignancies 66
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron. 64
BBB damage in aging causes brain iron deposits via astrocyte-neuron crosstalk and Hepc/Fpn1 pathway activation 64
Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. 60
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 59
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. 58
Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes 58
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging 58
Heterogeneity of hemochromatosis in Italy 56
The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy 56
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis 55
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis 55
Hereditary hemochromatosis: Generation of a transcription map within a refined and extended map of the HLA class I region 54
Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study 54
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 53
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 53
Iron: An Essential Element of Cancer Metabolism 53
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver 53
A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. 52
New polymorphisms and markers in the HLA class I region: relevance to hereditary hemochromatosis (HFE) 52
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters. 51
Two polymorphic repeats in the candidate region for the haemochromatosis gene 51
Brain iron deposits during aging: activation of the Hepc/Fpn1 pathway. 51
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. 50
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. 49
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation 48
Juvenile and adult hemochromatosis are distinct genetic disorders 48
Genetic haemochromatosis: genes and mutations associated with iron loading. 47
Mutations in transferrin receptor-2 in hemochromatosis type 3. 47
null 47
Commentary: Juvenile hemochromatosis in a Spanish family (by Montes-Cano et al.). 46
Identification of new BMP6 pro-peptide mutations in patients with iron overload 46
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. 45
Juvenile hemochromatosis locus maps to chromosome 1q. 45
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. 45
Molecular and clinical studies in hemochromatosis type 2 and 3 45
The natural history of hemochromatosis type 2. 45
Hereditary hemochromatosis: progress and perspectives 44
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 44
Hereditary Hemochromatosis 43
null 42
Non-HFE hemochromatosis: insights into regulation on iron metabolisms from novel iron loading disorders. 42
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 42
Fisiopatologia Molecolare del Matbolismo del ferro 41
TFR2 BETA ISOFORM HAS A ROLE IN CARDIAC IRON METABOLISM 41
Mutation analysis of the HLA-H gene in Italian hemochromatosis patients 40
Cloning of a new gene (FB19) within HLA class I region 40
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells 40
HETEROZYGOUS β-THALASSEMIA AND HOMOZYGOUS H63D HEMOCHROMATOSIS IN A CHILD: A 16-YEAR FOLLOW-UP 39
Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. 39
Natural history of juvenile haemochromatosis. 39
Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up. 38
Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. 38
Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient. 38
Hereditary hemochromatosis: a HpaI polymorphism within the HLA-H gene 38
Growth hormone (GH)-induced reconstitution of CD8+ CD28+ T lymphocytes in a rare case of severe lymphopenia associated with Juvenile Haemochromatosis and Turner's syndrome. 38
Analysis of NCOA4/Tfr2 as PB markers of iron increase during ageing 38
Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic–neuronal crosstalk to counteract iron dyshomeostasis during aging 37
Juvenile hemochromatosis. 37
Exclusion of ZIRTL as candidate gene of juvenile hemochromatosis and refinement of the critical interval on 1q21. 37
Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload 37
Totale 8.511
Categoria #
all - tutte 22.850
article - articoli 0
book - libri 0
conference - conferenze 4.290
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019456 0 0 0 0 0 0 0 78 28 81 189 80
2019/20201.449 51 56 71 169 92 243 156 139 139 140 99 94
2020/20211.134 97 49 81 60 138 78 112 48 142 77 81 171
2021/20221.522 75 53 53 129 71 69 119 102 81 148 338 284
2022/20232.002 225 162 61 225 205 514 159 97 171 36 91 56
2023/2024684 110 173 58 78 75 129 23 38 0 0 0 0
Totale 9.204